// App-Quantinova.ai

: Permanent seed brachytherapy for low risk prostate cancer, long term outcome, and urinary toxicity.

Researchers

Presenter

  • Hamid Raziee

Principal Investigators

  • Alejandro Berlin

  • Peter W. M. Chung

  • Joelle Antoine Helou

  • Haiyan Jiang

  • Juanita M. Crook

  • Charles N Catton

Medical Centers

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • iodine-125

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved